VALERION THERAPEUTICS, LLC
Valerion Therapeutics, LLC (formerly 4s3 Bioscience) is developing therapies for orphan genetic muscle diseases utilizing a novel antibody-based targeting system capable of enhanced intracellular delivery. Demonstrated pre-clinical in vivo data with the company’s two lead product candidates validates the potential of the 4s3 delivery platform for delivering muscle-protein fusions and treating multiple indications in the fields of muscular dystrophies and enzyme-deficiency disorders.
VALERION THERAPEUTICS, LLC
Industry:
Biotechnology Genetics Pharmaceutical Therapeutics
Founded:
2007-01-01
Address:
Medford, Massachusetts, United States
Country:
United States
Website Url:
http://www.valerion.com
Total Employee:
1+
Status:
Active
Contact:
978-341-8183
Email Addresses:
[email protected]
Total Funding:
21.2 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon WordPress Domain Not Resolving Apache Wordpress Plugins Microsoft Exchange Online
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Cognition Therapeutics
Cognition Therapeutics develops new therapeutics to treat patients suffering from Alzheimer’s disease and other neurodegenerative disorders.
Jounce Therapeutics
Jounce Therapeutics is developing cancer immune-therapies to harness the immune system to attack cancerous cells and tumors.
Current Advisors List
Founder
Investors List
KLP Enterprises
KLP Enterprises investment in Series A - Valerion Therapeutics, LLC
Official Site Inspections
http://www.valerion.com
- Host name: 76.76.21.21
- IP address: 76.76.21.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
